Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

T. J. A. van Nijnatten*, J. M. Simons, M. Moossdorff, L. de Munck, M. B. I. Lobbes, C. C. van der Pol, L. B. Koppert, E. J. T. Luiten, M. L. Smidt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)159-166
Number of pages8
JournalBreast Cancer Research and Treatment
Volume163
Issue number1
DOIs
Publication statusPublished - May 2017

Keywords

  • Breast cancer
  • Axillary lymph node
  • Neoadjuvant chemotherapy
  • Prognosis
  • DISSECTION
  • METASTASES
  • BIOPSY
  • METAANALYSIS
  • RECURRENCE
  • ONCOLOGY
  • THERAPY
  • TRIAL

Cite this